Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
316 studies found for:    Osteosarcoma
Show Display Options
RSS Create an RSS feed from your search for:
Osteosarcoma
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
Conditions: Osteosarcoma;   Localised High Grade Osteosarcoma of the Limbs
Interventions: Drug: Etoposide, Ifosfamide, Methotrexate;   Drug: Doxorubicin, Methotrexate
2 Completed Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
Conditions: Metastatic Osteosarcoma;   Relapsed Osteosarcoma
Interventions: Drug: Sorafenib;   Drug: Everolimus
3 Recruiting Study of Blood Samples From Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Intervention: Other: laboratory biomarker analysis
4 Recruiting Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Intervention: Other: laboratory biomarker analysis
5 Recruiting Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Conditions: Osteosarcoma;   Metastatic Osteosarcoma
Intervention: Drug: pazopanib
6 Not yet recruiting Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Conditions: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Osteosarcoma
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
7 Completed Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Ifosfamide, Carboplatin, Doxorubicin;   Procedure: Limb Sparing
8 Recruiting Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
Conditions: Osteosarcoma;   Paget's Disease;   Ewing Sarcoma
Intervention: Other: DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI
9 Active, not recruiting Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: cisplatin;   Drug: methotrexate;   Procedure: therapeutic conventional surgery;   Biological: peginterferon alfa-2b;   Drug: ifosfamide;   Drug: etoposide;   Procedure: quality-of-life assessment;   Other: questionnaire administration
10 Completed Phase II Study of Intravenous Rexin-G in Osteosarcoma
Condition: Osteosarcoma
Interventions: Genetic: Rexin-G Dose 1;   Genetic: Rexin-G Dose 2
11 Unknown  Diffusion Study on Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention:
12 Recruiting Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Conditions: Bone Cancer;   Chondrosarcoma;   Ewing's Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma
Interventions: Drug: Feraheme;   Procedure: MR Scan
13 Terminated A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
Conditions: Osteosarcoma;   Lung Metastases
Interventions: Drug: Dexrazoxane;   Drug: Doxorubicin;   Drug: Cisplatin;   Drug: G-CSF;   Drug: PEG-filgrastim;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna;   Drug: Leucovorin
14 Completed Sorafenib in Relapsed High Grade Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: sorafenib
15 Completed Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Etoposide;   Drug: Interferon Alpha
16 Completed Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
Condition: Osteosarcoma
Intervention: Drug: pre-surgical chemotherapy
17 Active, not recruiting A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Chemotherapy;   Drug: Endostar
18 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: 153Sm-EDTMP;   Other: Autologous Peripheral Blood or Bone Marrow Stem Cell Infusion;   Radiation: External Beam Radiotherapy
19 Completed Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Cisplatin;   Drug: Doxorubicin;   Drug: Methotrexate
20 Unknown  Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
Condition: Osteosarcoma
Interventions: Dietary Supplement: Curcumin powder;   Dietary Supplement: Ashwagandha extract

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years